Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
226 Cards in this Set
- Front
- Back
Most surgery prophylaxis DOC
|
Cefazolin
|
|
Moraxella catarrhalis
|
TMP-SMZ, Cephalosporin
|
|
N. gonorrhoeae
|
Ceftriaxone
|
|
N. menigitidis
|
Penicillin G
|
|
E. coli, Klebsiella, Proteus
|
Cefazolin, TMP-SMZ
|
|
Enterobacter, Citrobacter, Serratia
|
TMP-SMZ, quinalone, carbapenem
|
|
Shigella
|
Quinalone
|
|
Salmonella
|
TMP-SMZ, quinalone, cephalosporin (3rd gen)
|
|
Campylobacter
|
Erythromycin or azithromycin
|
|
Brucella
|
Doxycycline + rifampin or aminoglycoside
|
|
Helicobacter pylori
|
Bismuth + metronidazole + tetracycline or amoxicillin
|
|
Vibrio
|
Tetracycline
|
|
Pseudomonas
|
Antipseudomonal penicillin + aminoglycoside
|
|
Legionella
|
Azithromycin or quinalone + rifampin
|
|
Streptococcus (all)
|
Penicillin
|
|
Staph aureus
|
Penicillin (penicillinase-resistant if needed)
|
|
MRSA
|
Vancomycin
|
|
Enterococcus
|
Penicillin + aminoglycoside
Vacnomycin + aminoglycoside Dalfopristin |
|
Bacillus
|
Vancomycin
|
|
Listeria
|
Ampicillin
|
|
Nocardia
|
Sulfadiazine, TMP-SMZ
|
|
Gram positive anaerobes (clostridia, peptococcus, actinomyces, peptostreptococcus)
|
Penicillin, clindamycin
|
|
Gram neg. anaerobes (C. diff, bacteroides, fusobacterium, prevotella, porphyromonas)
|
Metronidazole
|
|
Mycoplasma pneumoniae
|
Tetracycline, erythromycin
|
|
Chlamydia (all)
|
Tetracycline
|
|
Borrelia
|
Doxycycline
|
|
Leptospira, Treponema
|
Penicillin
alt. Tetracycline |
|
Drugs used to treat TB
|
Rifampin
Isoniazid Pyrazinamide Ethambutol |
|
Best second line drugs for TB
|
Caperomycin
Kanamycin Fluoroquinalones |
|
Drugs used to treat leprosy
|
Rifampin
Dapsone Clofazimine |
|
Natural penicillin is DOC for...
|
Neisseria meningitidis
All Streptococcus Staph Aureus (penicillinase neg) Enterococcus (+aminoglycoside) Clostridia Leptospira Treponema |
|
Penicillinase resistant penicillins are DOC for...
|
Staph aureus (penicillinase pos)
|
|
Ampicillin is DOC for...
|
Listeria
|
|
Extended spectrum penicillins spectrum
|
Less gram pos.
More gram neg - H. influenzae, E. coli, Listeria, Proteus, Salmonella, Shigella Anaerobic in combo w/penicillinase inhibitors |
|
Cefazolin is DOC for...
|
Surgical prophylaxis
Proteus E. coli Klebsiella |
|
Ceftriaxone is DOC for...
|
N. gonorrhea
Penicillin-resistant S. pneumoniae |
|
Second generation cephalosporin spectrum
|
H. Influenzae
Enterobacter Neisseria sp. Proteus E. coli Klebsiella Serratia Moraxella |
|
Aztreonam clinical use
|
Gram negatives only including Pseudomonas
Good for patients with penicillin allergy |
|
Carbapenem spectrum
|
Broad spectrum including anaerobes & pseudomonas
|
|
Vancomycin is DOC for...
|
MRSA
C. diff superinfections |
|
Macrolide spectrum
|
Atypical pneumonias: Mycoplasma, Chlamydia, Legionella, Moraxella
Alternative to penicillin for Listeria, S.aureus, Strep sp. |
|
Clarithromycin & Azithromycin clinical use
|
More effective than Erythromycin for pneumonia - MAC & H.influezna
Chlamydia & gonorrhea |
|
Telithromycin clinical use
|
S. pneumonia resistant to erithromycin and penicillin
|
|
Chloramphenicol clinical use
|
Very wide spectrum, side effects limit use
Alternative for meningitis and gram neg. |
|
Tetracycline clinical use
|
Intracellular and blood borne
DOC for Mycoplasma, Chlamydia, Ricketssia, Vibrio Cholerae (alt. for spirochetes) Plague, Tularemia, Brucellosis, acne |
|
Tigecycline clinical use
|
Decreased resistance compared to Tetracyclines
Other resistant organisms - MRSA, MRSE, PESP, VRE Complicated skin infections |
|
Clindamycin clinical use
|
Anaerobes
Toxoplasmic encephalitis in AIDS pts |
|
Dalfopristin, Quinupristin clinical use
|
VRSE, VRSA, complicated skin infections
|
|
Aminogylcoside clinical use
|
Gram neg. enterics (synergistic with penicillins)
|
|
Streptomycin clinical use
|
Tularemia, bubonic plague, tuberculosis
|
|
Sulfonamide clinical use
|
DOC for Nocardia
UTIs, Pneumocystis carinii, Toxoplasmosis, Trachomatis |
|
Silver sulfadiazine use
|
Topical agent for burn wounds
|
|
TMP-SMX use
|
Uncomplicated UTIS, Moraxella
Shigella, Salmonella, Pneumocystis jiroveci, Nocarida, Listeria |
|
Nitrofurantoin clinical use
|
Acute and chronic UTIs
|
|
Methenamine mandelate clinical use
|
Chronic UTI, catheter prophylaxis
|
|
Nalidixic acid clinical use
|
UTIs caused by Proteus, E.coli, Enterobacter, Klebsiella
|
|
Fluoroquinalones clinical use
|
Best for gram neg. UTIs, GI infections (some gram pos)
Not effective against S.pneumoniae or anaerobes |
|
Levofloxacin clinical use
|
Expanded gram pos. coverage
Community acquired pneumonia Skin infections |
|
Gatifloxacin clinical use
|
Topical for ocular infections
|
|
Moxifloxacin & Gemifloxacin clinical use
|
Penicillin resistant S. pneumoniae
|
|
Mupirocin clinical use
|
Impetigo
|
|
Polymixin B&E, Colistimethate, Colistin clinical use
|
Topical application for wounds, burns
Otitis externa |
|
Ototoxicity
|
Aminoglycosides
Vancomycin Erythromycin i hAVE ears |
|
Visual toxicity
|
Ethambutol
Isoniazid Oh my IEs! |
|
Hematopoietic toxicity
|
Chloramphenicol
Sulfonamides |
|
Hemolytic anemia
|
Chloramphenicol
Nitrofurantoin Isoniazid |
|
Photosensitivity
|
Tetracyclines
Fluoroquinalones You're really Fucking Tan |
|
Seizures
|
Imipenem
|
|
Red man syndrome
|
Vancomycin
|
|
Vancomycin side effects
|
Otoxicity, nephrotoxicity, Red man syndrome
|
|
QT elongation (torsades de pointes)
|
Erythromycin
Flouroquinalones |
|
Macrolide side effects
|
GI disturbances (less with clarithro)
Elevated LFTs, jaundice Ototoxicity QT prolongation, torsades de pointes |
|
Gray baby syndrome
|
Chloramphenicol
|
|
Chloramphenicol side effects
|
Fatal aplastic anemia
Hemolytic anemia Gray baby syndrome |
|
Excellent tissue distribution
|
Chloramphenicol
|
|
Chelation
|
Tetracycline (Ca, Fe, Al)
Fluorquinalones (Mg) |
|
Deposition in bones/teeth
|
Tetracycline
|
|
Inhibition of ADH
|
Demeclyocycline
|
|
Psuedomembranous colitis
|
Clindamycin
|
|
High concentration in bones
|
Clindamycin
|
|
MAO inhibitor
|
Linezolid
|
|
Neuromuscular weakness
|
Aminoglycosides
|
|
Aminoglycoside side effects
|
Nephrotoxic
Ototoxic Neuromuscular weakness |
|
Kernicterus
|
Sulfonamides
|
|
Stevens-Johnson syndrome
|
Sulfonamides
|
|
Peripheral nerve damage
|
Sulfonamides
|
|
Tendon rupture
|
Fluoroquinalones
|
|
Fluoroquinolone side effects
|
Increased QT
Tendon rupture C/I in pregnancy and children |
|
Isoniazid side effects
|
Liver damage
Peripheral neuritis Hemolysis |
|
Pyrazinamide side effects
|
Nephrotoxic, Hepatotoxic
|
|
Ethionamide side effect
|
Neurologic complications
|
|
Cycloserine side effect
|
Peripheral neuropathy, CNS dysfunction, psychosis
|
|
Capreomycin side effect
|
Kidney damage
|
|
Dapsone side effects
|
Blood dyscrasias
Nasal obstruction |
|
Clofazimine side effects
|
Hepatitis
Crystalline deposits found in many organs at autopsy |
|
Thalidomide side effects
|
Extremely teratogenic
|
|
Nitrofurantoin side effects
|
Brown urine
Intersitial pulmonary fibrosis |
|
Renal toxicity
|
Cephalosporins
Vancomycin Aminglycosides Sulfonamides Keds are made out of CanVAS |
|
Hepatotoxicity
|
Tetracyclines
Isoniazid Erythromycin Clindamycin Sulfonamides kaTIE likes Chardonnay and Syrah |
|
Sulfonamide side effects
|
Crystulluria/nephrotoxicity
Kernicterus Blood dyscrasia Hepatotoxicity Steven Johnson syndrome Peripheral nerve damage |
|
Beta-lactam mechanism
|
Cell wall synthesis inhibitor
Inhibit transpeptidase (PBPs) Prevent crosslinking of peptides |
|
Beta-lactam resistance mechanisms
|
Penicillinase production (plasmid)
Alteration of PBPs (MRSA, DNA) Change of porins Lack of cell wall, peptidoglycan, or activation of autolytic enzymes |
|
Vancomycin mechanism
|
Cell wall synthesis inhibitor
Binds D-Ala-D-Ala Prevents elongation |
|
Vancomycin resistance mechanism
|
Mutation to D-Ala-D-Lac
|
|
Fosfomycin mechanism
|
Cell wall synthesis inhibitor
Inhibits one of initial steps Accumulation of of precursors |
|
Bacitracin mechanism
|
Cell wall synthesis inhibitor
Inhibits activation of phospholipid carrier Accumulation of subunits |
|
Cycloserine mechanism
|
Cell wall synthesis inhibitor
Competitive antagonist of D-alanine Inhibits incorportation into cell wall |
|
Macrolide mechanism (Erythromycin)
|
Protein synthesis inhibitor
Binds 50S Interferes with translocation |
|
Macrolide resistance mechanism (Erythromycin)
|
Methyltransferases alter binding site
|
|
Chloramphenicol mechanism
|
Protein synthesis inhibitor
Binds 50S Inhibits transpeptidation/peptidyl tranferase |
|
Choramphenicol resistance mechanism
|
Acetyltransferase inactivation
|
|
Tetracycline mechanism
|
Protein synthesis inhibitor
Binds 30S Prevent binding of incoming tRNA |
|
Tetracycline resistance mechanism
|
Pumped out of cell (plasmid)
|
|
Clindamycin mechanism
|
Protein synthesis inhibitor
Binds 50S Blocks peptidyl transferase/translocation |
|
Dalfopristin, Quinopristin mechanism
|
Protein synthesis inhibitor
Bind 50S |
|
Linezolid mechanism
|
Protein synthesis inhibitor
Bind 50S Prevent formation of 70S initiation complex |
|
Aminoglycoside mechanism
|
Protein synthesis inhibitor
Binds 30S Prevent formation of initiation complex Misreading of mRNA (wrong AA, termination) *Requires oxygen |
|
Aminoglycoside resistance mechanism
|
Enzymes that acetylate, phosphorylate or adenylate (plasmid)
|
|
Sulfonamide mechanism
|
Inhibit folic acid synthesis
PABA antagonist, blocks dihydropeteroate synthase |
|
Sulfonamide resistance mechanisms
|
Decreased sensitivity of target enzymes
Increased formation of PABA Use of exogenous folate |
|
Trimethorprim mechanism
|
Blocks dihydrofolate reductase
|
|
Metheamine mandelate mechanism
|
Decomposes to formaldehyde
|
|
Flouroquinalone mechanism
|
Inhibit DNA gyrase (topoisomerase)
|
|
Flouroquinalone resistance mechanism
|
Mutation in DNA gyrase
Pumped out |
|
Daptomycin mechanism
|
Binds membrane and causes depolarization
|
|
Mupirocin mechanism
|
binds isoleucyl-tRNA synthetase
|
|
Polymixin, Colistin mechanism
|
Bind phospholipds in gram-neg cell wall and increase permeability
|
|
Isoniazid mechanism
|
Inhibits synthesis of mycolic acid
|
|
Rifampin mechanism
|
Inhibits DNA-dependent RNA polymerase activity
|
|
Ethambutol mechanism
|
Inhibits arabinosyl transferase involved in cell wall synthesis
|
|
Pyrazinamide mechanism
|
Inhibits trans-translation in non-replicating bacteria
|
|
Dapsone mechanism
|
PABA antagonist
|
|
Clofazamine mechanism
|
Binds bacterial DNA, inhibits reproduction and growth
|
|
Thalidomide mechanism
|
Decreases levels of TNF-a
|
|
Bactericidal drugs
|
All CWS inhibitors
Aminoglycosides (conc. dep) Fluoroquinolones (conc. dep) Daptomycin Rifampin Polymyxins |
|
Bacteriostatic drugs
|
All protein synthesis inhibitors (except Aminglycosides)
Sulfonamides (except in urine) Nitrofurantoin (except in urine) Isoniazid, Ethambutol, Trimethorprim (use in combo) |
|
Naficillin
Oxacillin Cloxacillin Methicillin |
Penicillinase-resistant penicillins
(Beta-lactam) |
|
Ampicillin
Amoxicillin |
Extended spectrum penicillins
(Beta-lactam) |
|
Carbenicillin
Ticarcillin Mezlocillin Piperacillin |
Anti-pseudomonal penicillins
(Beta-lactam) |
|
Cefazolin
Cephalexin monohydrate Cephradine |
First generation cephalosporins
(Beta-lactam) |
|
Cefoxitin
Cefamandole Cefaclor Cerfuroxime Cefprozil Loracarbef |
Second generation cephalosporins
(Beta-lactam) |
|
Cefotaxime sodium
Cefoperazone Ceftazidime Ceftriaxone Cefixime |
Third generation cephalosporins
(Beta-lactam) |
|
Cefepime class
|
Fourth generation cephalosporin
(Beta-lactam) |
|
Aztreonam class
|
Monobactam
(Beta-lactam) |
|
Imipenem
Meropenem Ertapenem |
Carbapanems
(Beta-lactam) |
|
Clavulanic acid
Sulbactam Tazobactam |
Beta-lactamase inhibitors
|
|
Erythromycin
Clarithromycin Azithromycin Telithromycin |
Macrolides
|
|
Gentamicin
Neomycin Amikacin Tobramycin Streptomycin |
Aminoglycosides
|
|
DOC for herpes viruses (HSV, VZV, EBV)
|
Acyclovir
Valacyclovir - oral Genital lesions, keratitis, encephalitis (IV) |
|
Acyclovir toxicity
|
Somnolence with zidovudine
Otherwise well tolerated, safe in pregnancy |
|
Acyclovir mechanism
|
Guanosine analog
Activated by viral thymidine kinase Inhibits DNA synthesis |
|
OTC cold sore treatment
|
Docosanol
|
|
Docosanol mechanism
|
Inhibits herpes virus fusion
|
|
Ganciclovir mechanism
|
Similar to acyclovir
|
|
Ganciclovir use
|
Effective against CMV and Herpes
Prophylaxis in transplant patients Valganciclovir - oral prodrug |
|
Ganciclovir toxicity
|
Neutropenia, thrombocytopenia
|
|
DOC for resistant CMV & herpes
|
Foscarnet
|
|
Foscarnet mechanism
|
Inhibits viral DNA polymerase
|
|
Oseltamivir/Zanamivir use
|
Influenza A&B
Oseltamivir - oral Zanamivir - nasal |
|
Oseltamivir mechanism
|
Neuraminidase inhibitors
Block release of progeny |
|
Oseltamivir/Zanamivir side effects
|
Oseltamivir - nausea/vomiting
Zanamivir - bronchospasm, pulmonary function |
|
Amantidine/rimantidine mechanism
|
Blocks viral uncoating (M2 protein)
|
|
Amantidine use
|
Influenza A only
Parkinson's |
|
Amantidine side effects
|
Hallucinations
Ataxia, dizziness |
|
Ribivarin use
|
RSV, chronic hepatitis C
|
|
Ribivarin toxicity
|
Anemia
Category X teratogen |
|
Palvizumab
|
RSV antibody
|
|
DOC for chronic hepatitis B
|
Lamivudine
|
|
Telaprevir/Boceprevir mechanism/use
|
Protease inhibitors for Hep C genotype 1
|
|
Telaprevir/Boceprevir side effects
|
Anemia, neutropenia, rash
|
|
Zifovudine
Lamivudine Didanosine Tenofovir Emticitabine |
Nucleoside reverse transcriptase inhibitors
|
|
Common NRTI combination
|
Zifovudine & lamivudine
|
|
NRTIs used in naive patients
|
Tenofovir & Emtricitabine
|
|
NRTI use
|
Part of HAART therapy, always use 2
Decrease risk of transmission in pregnancy |
|
NRTI side effects
|
Neutropenia, anemia
Lactic acidosis Hepatotoxicity |
|
NRTI that causes peripheral neuropathy
|
Didanosine
|
|
Efavirenz
Nevirapine |
Non-nucleotide reverse transcriptase inhbitors
Evafirenz cannot be used in pregnancy |
|
Which HIV drugs are metabolized by CYP3A?
|
NNRTIs, protease inhibitors
|
|
Atazanavir
Lopinavir Saquinavir Ritonavir |
Protease inhibitors
Atazanavir is DOC |
|
Protease inhibitor side effects
|
Lipodystrophy - buffalo hump, increase abdominal fat, thin face
Hyperglycemia, hyperlipidemia |
|
What can be used to increase bioavailability of protease inhibitors?
|
Ritonavir at subtherapeutic doses (inhibits CYP3A)
Grapefruit juice, fatty foods |
|
Enfuvirtide mechanism/side effect
|
Fusion inhibitor - binds GP41
Swelling at injection site |
|
Amphotericin B mechanism
|
Interacts with ergosterol in cell membrane creating pores
|
|
Amphotericin B use
|
DOC for most systemic fungal infections
Exceptions: Aspergillus, combined w/flucytosine for Cryptococcus |
|
Amphotericin B toxicity
|
Fever/chills
Nephrotoxicity Hepatoxicity |
|
Nystatin mechanism/use
|
Same as amphotericin
Thrush |
|
Cryptococcus treatment
|
Flucytosine + amphotericin B
|
|
Flucytosine mechanism
|
Converted to 5-flourouracil, inhibits DNA synthesis
|
|
Flucytosine toxicity
|
Bone marrow suppresion
|
|
Aspergillus DOC
|
Voriconazole
|
|
Azole mechanism
|
Inhibit ergosterol synthesis
Inhibit fungal CYP3A enzyme |
|
Fluconazole use
|
Excellent CNS penetration - cryptococcal meningitits
|
|
Which azole does NOT inhibit CYP3A?
|
Fluconazole
|
|
Azole side effects
|
Inhibit CYP3A - drug interaction, gynecomastia
|
|
Capsofungin mechanism
|
Inhibit cell wall synthesis, bind B-glucan
|
|
Capsofungin use
|
Invasive aspergillosis
Esophageal candidiasis |
|
Griseofulvin mechanism
|
Binds microtubules, disrupts mitotic spindle
Accumulates in keratin-containing tissues |
|
Griseofulvin use
|
Oral treatment of onchyomycosis
|
|
Terbinafine mechanism
|
Interferes with ergosterol synthesis by inhibiting sqaulene oxidase
|
|
Terbinafine use
|
Onchyomycosis- oral or topical
|
|
Which malarial drug is the only tissue schizonticide?
|
Primaquine - the rest are all blood schizonticides
|
|
Which malaria strain has hypnozoites?
|
Vivax, ovale - can only cure with primaquine/tissue schizonticide
|
|
Which malaria strain is most severe?
|
Falciprum - cure with blood schizonticide
|
|
DOC for sensitive malarial strains
|
Chloroquine
|
|
DOC for chloroquine-resistant P. vivax
|
Quinidine
|
|
DOC for chloroquine resistant P. falciprum
|
Malarone
|
|
When is doxycycline/tetracycline used?
|
In combination with Quinidine for severe malaria
Prophylaxis of MDR malaria |
|
DOC for malaria prophylaxis
|
Chloroquine
|
|
DOC for chloroquine-resistant malaria prophylaxis
|
Mefloquine
Alternatives - Doxycycline, Malarone |
|
Chloroquine & quinidine toxicity
|
These only occur at high doses or cholorquine
Tinnitus, dizziness, headache, visual disturbances Arrythmias |
|
Mefloquine toxicity
|
Sleep disturbances, psychosis
|
|
Primethamine/sulfadioxine use in malaria
|
Presumptive treatment
|
|
Primiquine toxicity
|
Hemolysis in G6PD deficiency
Teratogenic |
|
Metronidazole is DOC for...
|
E. histolytica
Giardia Trichomonas |
|
Effective luminal agents for E. histolytica
|
Iodoquinol
Paramomycin |
|
DOC for pneumocystosis
|
TMP-SMX
|
|
DOC for toxoplasmosis
|
Pyrimethamine + sulfadiazine
|
|
Mebenazole is DOC for...
|
Roundworms
Pinworm Whipworms Hookworms Trichonosis |
|
DOC for tapeworms
|
Niclosamide
|
|
DOC for schistosomiasis and all flukes
|
Praziquantel
|
|
Mebendazole mechanism
|
Binds tubulin, interferes with protein function
|
|
Pyrantel pamoate mechanism
|
Cholinesterase inhibitor
|
|
Praziquantel mechnanism
|
Increases Ca permeability, paralysis of the worm
|
|
Nephrotoxic
|
Gancyclovir
Amphotericin |
|
Teratogenic
|
Ribivarin
Efavirenz Mebendazole Primiquine |
|
Hepatotoxic
|
Terbinafine
Amphotericin B NRTIs |